Skip to main content

Table 2 General traits and physical activity levels of overweight/obese patients with non-alcoholic fatty liver disease (NAFLD)

From: Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

Variables

Nanocurcumin (n = 42) n(%) or Mean(SD)

Placebo (n = 42) n(%) or Mean(SD)

P-value

Age (yrs)

41.8(5.6)

42.5(6.2)

0.2*

Gender

male

23(54.8)

23(54.8)

1.0**

female

19(45.2)

19(45.2)

Height (cm)

167.8(9.8)

167.7(9.0)

0.8*

Marriage status

single

5(11.9)

7(16.7)

0.5**

married

37(88.1)

35(83.3)

Job status

employee, free job/retired

31(73.8)

25(59.5)

0.1**

housewife, unemployed

11(26.2)

17(40.5)

Education level

up to associate degree

21(50)

20(47.6)

0.8**

Bachelor and higher

21(50)

22(52.4)

Economic level

Low (≤3 living items)

0(0)

0(0)

0.8**

moderate (4–6 living items)

19(45.2)

18(42.9)

High (≥7 living items)

23(54.8)

24(57.1)

Physical activity level (Baseline)

low (< 600 MET-minutes/week)

31(73.8)

28(66.7)

0.4**

Moderate (600 to < 1500 MET-minutes/week)

11(26.2)

14(33.3)

High (≥ 1500 MET-minutes/week)

0(0)

0(0)

Physical activity level (After 3 months)

low (< 600 MET-minutes/week)

27(64.3)

26(61.9)

0.8$

Moderate (600 to < 1500 MET-minutes/week)

15(35.7)

16(38.1)

High (≥ 1500 MET-minutes/week)

0(0)

0(0)

Fatty liver (Baseline)

No

0(0)

0(0)

0.5**

Yes

Mild

35(83.3)

37(88.1)

Moderate

7(16.7)

5(11.9)

Severe

0(0)

0(0)

Fatty liver (After 3 months)

No

20(47.6)

5(11.9)

< 0.001**

Yes

Mild

21(50.0)

33(78.6)

Moderate

1(2.4)

4(9.5)

Severe

0(0)

0(0)

  1. *Mann-Whitney; **Chi-square; $Fisher exact test